News Related to HER2-Positive Disease

Related coverage linked through entity extraction aliases.

ctDNA Detection and CCR5 Inhibition Show Promise in Triple-Negative Breast Cancer

Mar 07, 2026

New research highlights circulating tumor DNA as a prognostic tool in early-stage triple-negative breast cancer, while leronlimab demonstrates long-term survival signals in heavily pretreated metastatic patients through CCR5 receptor blockade.

ASCO Updates Guideline on Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer

Mar 01, 2026

New ASCO guideline emphasizes biomarker-driven treatment for advanced gastroesophageal cancer, recommending upfront testing for HER2, PD-L1, MSI/MMR, and CLDN18.2 to guide immunotherapy and targeted therapy selection.